June 29, 2021 – A new original science category being featured at the American Society of Echocardiography (ASE) 2021 virtual meeting, June 18-21, focused on the utilization of cardiac ultrasound and ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues.This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
June 29, 2021 – A new original science category being featured at the American Society of Echocardiography (ASE) 2021 ...
June 29, 2021 – Echocardiography with ultrasound enhancing agents (UEAs) has proven to be a valuable imaging procedure ...
May 12, 2021 — According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 ...
As part of the Consolidated Appropriations Act of 2018, pass-through payment status for LUMASON® (sulfur hexafluoride ...
May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a very ...
October 4, 2019 – RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced ...
August 28, 2019 — A new 3-D magnetic resonance imaging (MRI) computing technique developed by scientists in WMG at the ...
August 7, 2019 — Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most ...
July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic ...
Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax ...
Thomas Porter, M.D., FASE, the Theordore F. Hubbard Distinguished Chair of Cardiology and a professor of medicine at the ...

Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a ...
As part of the Consolidated Appropriations Act of 2018, pass-through payment status for LUMASON® (sulfur hexafluoride ...
May 9, 2019 — Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety ...
March 7, 2019 — National and international ultrasound societies are urging the U.S. Food and Drug Administration to ...